Comprehensive Study Guide for Gastrointestinal and Histamine Receptor Medications

Introduction to Histamine Receptors

• Histamine Types Overview:     * Histamine-1 ($H_1$): Primarily associated with allergic reactions and inflammatory responses.     * Histamine-2 ($H_2$): Primarily located in the stomach; these receptors regulate the secretion of gastric acid.

• Histamine Release Consequences:     * Increased Body Secretions: Occurs in salivary, gastric, lacrimal, and bronchial glands.     * Smooth Muscle Constriction: Affects the lungs (bronchoconstriction) and the stomach.     * Vasodilation and Capillary Permeability: Leads to the movement of fluid out of blood vessels and into the tissue, resulting in edema and a drop in blood pressure.     * Inflammatory Cascade: Includes symptoms like running or watery eyes, coughing, sneezing, and potential severe reactions such as anaphylaxis, angioedema (swelling beneath the skin), and responses to insect bites.

Histamine-1 ($H_1$) Receptor Antagonists (Antihistamines)

• Mechanism of Action:     * Competitive Blocking: They block the action of histamine at the $H_1$ receptor site by competing with histamine for unoccupied receptors.     * Prevention vs. Reversal: They are more effective at preventing histamine-induced actions than reversing them. Therefore, they should be administered early in an allergic response before all histamine has bound to receptors.     * Drug Example: Diphenhydramine (Benadryl) is a common first-generation antihistamine.

• Effects of $H_1$ Blockade:     * Cardiovascular: Reduces blood vessel dilation and reduces capillary permeability (prevents "leaky" vessels).     * Smooth Muscle: Opposite of histamine; prevents broncho- and gastro-constriction.     * Secretions: Blocks salivary, gastric, lacrimal, and bronchial secretions, leading to a drying effect.

• Indications for Use:     * Allergic rhinitis and allergic reactions.     * Anaphylaxis and angioedema.     * Motion sickness.     * Parkinson’s disease.     * Sleep disorders/insomnia (due to sedative effects).

• Side Effects and Adverse Effects:     * Anticholinergic Effects: Characterized by "drying" (dry mouth, constipation, difficulty urinating, and vision changes).     * Sedation: Ranges from mild drowsiness to deep sleep.

• Contraindications:     * Narrow-Angle Glaucoma: Due to increased pressure and vessel constriction in the eyes.     * Cardiac Disease and Hypertension: Caused by the potential for vasoconstriction.     * Respiratory Conditions: Use with caution or avoid in Chronic Obstructive Pulmonary Disease (COPD) or bronchial asthma unless supervised.     * Kidney Disease.     * Known Drug Allergy.

Histamine-2 ($H_2$) Receptor Antagonists

• Mechanism of Action:     * Acid Reduction: Blocks $H_2$ receptors on acid-producing cells in the stomach.     * Ion Inhibition: Decreases hydrogen ($H^+$) ion production, which directly results in decreased stomach acid acidity.

• Routes of Administration:     * Oral (PO): Available over the counter in lower dosages.     * Intravenous (IV): Used for inpatient care.

• Nursing Considerations:     * Timing: Must be taken $30$ minutes before meals. Taking it after eating is ineffective because the process of acid production (triggered by food in the esophagus) has already escalated.     * Smoking Interaction: Smoking decreases the effectiveness of $H_2$ antagonists.

• Indications:     * Peptic Ulcer Disease (PUD).     * Gastroesophageal Reflux Disease (GERD).     * $H. pylori$ infections.     * General acid indigestion and heartburn.

• Side Effects:     * Headache and dizziness.     * Drowsiness.     * Diarrhea or constipation (specifically frequency and consistency management).

Proton Pump Inhibitors (PPIs)

• Mechanism of Action:     * Total Inhibition: PPIs provide a complete block of the release of hydrogen ($H^+$) ions (protons). These ions dictate the acidity of gastric liquids.     * Inhibition vs. Decrease: While $H_2$ blockers decrease acid, PPIs stop the production process more comprehensively (total inhibition of gastric acid secretion).

• Drug Identification: Generally end in the suffix "-prazole" (e.g., Pantoprazole, Omeprazole).

• Administration:     * Route: Oral.     * Timing: Should be taken before meals.     * Duration: Intended for short-term use only, typically $4$ to $8$ weeks (one to two months).

• Indications:     * Peptic ulcers, GERD, and $H. pylori$.     * Potentially useful for patients post-gastric bypass to manage acid production in the reduced stomach size.

• Side Effects:     * Headache, nausea, rash, and weakness.

• Adverse Effects:     * Rebound Acid: Increased acid production occurring after stopping the medication.     * $C. diff$ Diarrhea: Risk increases because the lack of stomach acid allows bacteria to survive more easily.     * Skin Condition: Steven Johnson Syndrome (SJS), characterized by the skin sloughing off.     * Metabolic/Structural: Hypomagnesemia (low magnesium), osteoporosis, and increased risk of fractures.

Mucosal Protectants: Sucralfate (Carafate)

• Mechanism of Action:     * Coding/Coating: It coats the entire digestive tract (esophagus and stomach) to protect the mucosal lining from acid. It acts as a physical barrier rather than a chemical neutralizer.

• Administration:     * Route: Oral.     * Timing: Must be taken on an empty stomach.     * Protocol: At least $1$ hour before meals and at bedtime.

• Drug Interactions (Contraindicated Co-administration):     * Antacids: Antacids interfere with the absorption of Sucralfate.     * Specific Medications: Caution or avoidance required with Digoxin, Warfarin (Coumadin), Ciprofloxacin, and Phenytoin.

• Indications:     * Acute duodenal ulcers, gastric ulcers, and GERD.

• Side Effects:     * Dry mouth, upset stomach, gas, nausea, and constipation.

Antacids

• Mechanism of Action:     * Neutralization: Antacids work by neutralizing existing stomach acid. They do not reduce the production of acid, but rather neutralize the pH.

• Four Primary Types:     1. Aluminum hydroxide.     2. Calcium carbonate.     3. Sodium bicarbonate.     4. Magnesium carbonate hydroxide.

Questions & Discussion

• Q: Why block $H_1$ receptors?
  A: To prevent allergic reactions, which cause symptoms like runny eyes, coughing, and sneezing when histamine is released.

• Q: What is the risk of giving antihistamines to patients with Narrow-Angle Glaucoma?
  A: It is contraindicated because it increases ocular pressure by constricting vessels in the eyes.

• Q: When should a patient be assessed before giving an antihistamine?
  A: It is most important to assess for a history of urinary retention. Because antihistamines have anticholinergic (drying) effects, they can significantly worsen pre-existing urinary retention.

• Dialogue on Sucralfate and NG Tubes: The instructor shared an anecdote about administering Carafate via a Nasogastric (NG) tube. A neonatologist clarified that the drug is intended to coat the entire mucosal lining from the esophagus down, not just the stomach, emphasizing that its protective action is widespread throughout the digestive tract.

• Q: Is there a specific number for taking PPIs before meals?
  A: While the instructor noted a strict $30$-minute rule for $H_2$ blockers, they stated only that PPIs should be taken "before meals" without a specific minute threshold provided in this lecture.